Study Title: A012301: LoTam: A Randomized, Phase III Clinical Trial of LowDose Tamoxifen for Selected Patients with Molecular Low-risk EarlyStage Breast Cancer
For more information about the trial above please contact the study team:Lexington Medical CenterAffiliate Principal Investigator, Madden, Steven, at samadden@lexhealth.org.Medical University of South CarolinaPrincipal Investigator, Sivapiragasam, Abirami, at sivapira@musc.edu.Study Coordinator, Gelardi, Theresa, at gelardi@musc.edu.Trial opened at the following institutions: Medical University of South Carolina, Lexington Medical Center